Piramal Pharma Ltd (PPL) on Tuesday received Rs 3,523 crore on closure of the transaction for 20 per cent equity investment from CA Alchemy Investments, an affiliated entity of CAP V Mauritius, which is an investment fund managed and advised by affiliated entities of the Carlyle Group Inc.